Calvert US Select Equity ETF
CVSE
CVSE was delisted on the 14th of October, 2025.
4 hedge funds and large institutions have $47M invested in Calvert US Select Equity ETF in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and closing their positions.
130% more capital invested
Capital invested by funds: $20.4M → $47M (+$26.6M)
100% more funds holding
Funds holding: 2 → 4 (+2)
84.6% more ownership
Funds ownership: 93.14% → 177.74% (+85%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$21.3M |
| 2 |
BFEC
Benjamin F. Edwards & Company
St. Louis,
Missouri
|
+$688K |
| 3 |
Goldman Sachs
New York
|
+$188K |
| 4 |
HI
Harbour Investments
Madison,
Wisconsin
|
+$37.8K |
Top Sellers
CVSE Hedge Fund Activity: Q4 2023 in Review
4 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Calvert US Select Equity ETF (CVSE) for Q4 2023, worth a combined $47M — up 130% from $20.4M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CVSE positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $21.3M.
- 4 institutional investors held Calvert US Select Equity ETF (CVSE) as of Q4 2023, up from 2 in Q3 2023.
- Funds reported $47M of Calvert US Select Equity ETF stock for Q4 2023, up 130% quarter-over-quarter.
- 2 funds opened new Calvert US Select Equity ETF positions in Q4 2023 and 0 closed out, a net change of +2 holders.
- The largest Calvert US Select Equity ETF buyer in Q4 2023 was Morgan Stanley, an estimated $21.3M added.
Based on aggregated 13F filings for Q4 2023.